Filing Details
- Accession Number:
- 0001144204-14-033559
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-27 10:23:16
- Reporting Period:
- 2014-05-22
- Filing Date:
- 2014-05-27
- Accepted Time:
- 2014-05-27 10:23:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1518647 | P Robert Gasparini | C/O Neogenomics, Inc. 12701 Commonwealth Drive Suite 9 Fort Myers FL US 33913 | Chief Science Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-22 | 100,000 | $0.25 | 108,439 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2014-05-22 | 100,000 | $3.49 | 8,439 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | Disposition | 2014-05-22 | 100,000 | $0.25 | 0 | $0.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 325,000 | 2005-01-03 | 2015-01-03 | No | 4 | X | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | $1.47 | 2007-02-13 | 2017-02-13 | 0 | 100,000 | Direct |
| Common Stock | Stock Option (Right to buy) | $0.80 | 2008-03-12 | 2015-03-12 | 0 | 584,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $0.62 | 2009-12-31 | 2016-02-01 | 0 | 150,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2017-02-13 | 0 | 100,000 | Direct |
| 2015-03-12 | 0 | 584,000 | Direct |
| 2016-02-01 | 0 | 150,000 | Direct |
Footnotes
- On March 12, 2008 Mr. Gasparini was granted an option to puchase 784,000 shares. The first vesting and exercisable date was March 12, 2008. On this date 24,000 options vested and then there was to be 45 additional monthly vesting of 8,000 shares for a total of 384,000 options. Included in this grant were 400,000 non-qualified options with an initial vesting on March 12, 2008. From this grant 200,000 options were cancelled. Of the remaining 200,000 non-qualified options 200,000 are vested and exercisable.
- On February 2, 2009 Mr. Gasparini was granted an option to purchase 200,000 shares. These were performance options which vest based on various milestones. To date 150,000 shares are vested and exercisable and 50,000 shares have been cancelled.
Billionaire Hedge Funds
